Search
for
Sort by
Research 30 of 1000+
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Skin toxicity of anti‐cancer therapy
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Lupeol: an updated review utilizing AI-assisted predictive tools for enhanced therapeutic insights into lupeol’s potential for alopecia management
- MARIO LACOUTURE: How Do I Treat a Patient with Dermatologic Toxicities to EGFR Inhibitors?
- 329 Mechanisms of Cutaneous Adverse Events during Targeted Cancer Therapy
- 308 Epidermal keratinocytes regulate bacterial immune responses and host defense through EGFR
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- 1030 EGFR protects the upper hair follicle from staphylococcus driven folliculitis
- Drug Repurposing Patent Applications April–June 2021
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- The TRPM5 Antagonist Triphenylphosphine Oxide Increases Sebaceous Lipogenesis and Modulates Immune Phenotype of Human Sebocytes in a TRPM5‐Independent Manner
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- 1338 Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- ISID1338 - Epidermal growth factor receptor protects from immune privilege collapse and scarring hair follicle destruction
- Management of Toxicities of Targeted Therapies
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- Abnormal hair growth in patients (pts) with metastatic colorectal cancer (mCRC) treated with the anti-epidermal growth factor receptor (EGFr) monoclonal antibody (mAb) panitumumab (Pmab)
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Androgen receptor: A promising therapeutic target in breast cancer
- Research progress on mechanisms of skin aging and anti-aging strategies
- Dermatologic Reactions to Targeted Therapy
- Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Immunomodulatory roles of regulatory T cells in cutaneous wound healing: mechanisms and therapeutic opportunities